Schering-Plough's CEO says its latest quarterly report underscores that the company's turnaround is on track [1]. Fred Hassan (photo) said that its bottom line is growing faster than the top line, giving him cause to call his three-year plan a success. One analyst said that Schering-Plough would have to diversify beyond its successful cholesterol management franchise to continue its turnaround. Report [2]
Links:
[1] http://www.fiercebiotech.com/story/schering-plough-s-turnaround-plan-may-include-buyouts/2006-08-02
[2] http://www.cnbc.com/id/16873311